Interleukin 17D (IL17D) (N-Term) Peptide
Aperçu rapide pour Interleukin 17D (IL17D) (N-Term) Peptide (ABIN8103347)
Antigène
Origine
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- IL17D Peptide - N-terminal region
-
Séquence
- MLVAGFLLAL PPSWAAGAPR AGRRPARPRG CADRPEELLE QLYGRLAAGV
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-IL17D Antibody(ARP57724_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- IL17D (Interleukin 17D (IL17D))
-
Sujet
-
Background Information: The protein encoded by this gene is a cytokine that shares the sequence similarity with IL17. The treatment of endothelial cells with this cytokine has been shown to stimulate the production of other cytokines including IL6, IL8 and CSF2/ GM-CSF. The increased expression of IL8 induced by this cytokine was found to be NF-kappa B-dependent.
Alternative Symbols: FLJ30846, IL-17D, IL-22, IL-27, IL27
-
Poids moléculaire
- 21kDa
-
ID gène
- 53342
-
NCBI Accession
- NP_612141
-
UniProt
- Q8TAD2
Antigène
-
